Overview

Aprepitant to Mitigate Opioids' Cognitive Side Effects

Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Morphine and similar substances (called opioids) are often prescribed for moderate to severe pain, such as after a surgery, thus allowing for minimal pain and a better recovery. Unfortunately various, non-dangerous side effects from opioids occur often that limit the way patients feel and can take of themselves, despite otherwise good pain control and minimal limitations from the surgery itself.
Phase:
N/A
Details
Lead Sponsor:
University of Arizona
Treatments:
Aprepitant
Fosaprepitant